Trial
NCT04531176
EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
The Cleveland Clinic
Collaborators
—
Condition
Type 2 Diabetes
Intervention
Weight Management Program (WMP)
Why stopped
After an unplanned yet IRB approved interim analysis, it was found that there was not a significant difference between the 3 arms of the study. The study was closed due to futility. All Patients are off study and this study will not resume.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19